Subscribe
Webinars
White Papers
Buyer's Guide
PhotonicsNXT
Get Published!
Lasers/Sources
Detectors/Imaging
Optics
Bio & Life Sciences
Laser Processing
Test/Measurement
Science & Research
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Nasdaq Composite
SPX
Gold
Crude+Oil
LFW Photonics Market Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Silence Therapeutics Plc - American Depository Share
(NQ:
SLN
)
6.330
+0.560 (+9.71%)
Streaming Delayed Price
Updated: 1:40 PM EDT, May 20, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Silence Therapeutics Plc - American Depository Share
< Previous
1
2
3
Next >
Let's uncover which stocks are experiencing notable gaps during today's session.
↗
May 12, 2026
Via
Chartmill
Keep an eye on the top gainers and losers in Wednesday's session.
↗
May 06, 2026
Via
Chartmill
Traders are paying attention to the gapping stocks in Wednesday's session.
↗
April 29, 2026
Via
Chartmill
Top movers in Thursday's session
↗
April 23, 2026
Via
Chartmill
Deep Dive Into Silence Therapeutics Stock: Analyst Perspectives (7 Ratings)
↗
March 04, 2025
Via
Benzinga
Earnings Scheduled For February 27, 2025
↗
February 27, 2025
Via
Benzinga
Deep Dive Into Silence Therapeutics Stock: Analyst Perspectives (7 Ratings)
↗
February 03, 2025
Via
Benzinga
The Analyst Landscape: 6 Takes On Silence Therapeutics
↗
December 10, 2024
Via
Benzinga
Monday's session: gap up and gap down stocks
↗
April 06, 2026
Via
Chartmill
Here are the top movers in Monday's session.
↗
March 30, 2026
Via
Chartmill
Top stock movements in today's session.
↗
March 27, 2026
Via
Chartmill
Keep an eye on the top gainers and losers in Friday's session.
↗
March 27, 2026
Via
Chartmill
Which stocks are gapping on Friday?
↗
March 27, 2026
Via
Chartmill
Top movers analysis one hour before the close of the markets on 2026-03-26: top gainers and losers in today's session.
↗
March 26, 2026
Via
Chartmill
Here are the top movers in Thursday's session.
↗
March 26, 2026
Via
Chartmill
These stocks that are showing activity before the opening bell on Thursday.
↗
March 26, 2026
Via
Chartmill
Top movers in Friday's session
↗
March 20, 2026
Via
Chartmill
Which stocks are moving on Thursday?
↗
March 12, 2026
Via
Chartmill
Get insights into the top gainers and losers of Thursday's pre-market session.
↗
March 05, 2026
Via
Chartmill
Bausch Health’s Slow Rebuild Faces New Scrutiny After Lombard Odier Cuts Its Stake
↗
December 10, 2025
Bausch Health’s valuation suggests potential, but the stake cut shows how far the company still has to go to earn back full investor confidence.
Via
The Motley Fool
12 Health Care Stocks Moving In Tuesday's After-Market Session
↗
October 21, 2025
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
October 21, 2025
Via
Benzinga
Silence (SLN) Q2 Revenue Drops 71%
↗
August 07, 2025
Via
The Motley Fool
12 Health Care Stocks Moving In Tuesday's After-Market Session
↗
June 03, 2025
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
May 13, 2025
Via
Benzinga
These stocks are moving in today's pre-market session
↗
April 01, 2025
Discover the top movers in Tuesday's pre-market session and stay informed about market dynamics.
Via
Chartmill
Wall Street's Top 10 Stock Calls This Week - Saturday, Feb. 15
↗
February 15, 2025
What has Wall Street been buzzing about this week? Here is a look at the top 5 buy calls and the top 5 sell calls made by Wall Street's best analysts during the trading week of Feb. 10-14, 2025.
Via
Talk Markets
Topics
Stocks / Equities
This IBM Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
↗
February 11, 2025
Via
Benzinga
Top 3 Health Care Stocks That May Explode In Q4
↗
December 18, 2024
Via
Benzinga
Silence Therapeutics' Zerlasiran Has Competitive Concerns: Analyst
↗
November 19, 2024
Silence Therapeutics' Phase 2 data shows zerlasiran achieves over 80% Lp(a) reduction in ASCVD patients but faces dosing frequency challenges.
Via
Benzinga
< Previous
1
2
3
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
